These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11821733)

  • 1. The antineoplastic drug Paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model.
    Tange S; Scherer MN; Graeb C; Weiss T; Justl M; Frank E; Andrassy J; Jauch KW; Geissler EK
    Transplantation; 2002 Jan; 73(2):216-23. PubMed ID: 11821733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer.
    Tange S; Scherer MN; Graeb C; Andrassy J; Justl M; Frank E; Jauch KW; Geissler EK
    Transpl Int; 2003 Jul; 16(7):471-5. PubMed ID: 12677363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.
    Hanaway MJ; Geissler EK; Wang J; Fechner JH; Buelow R; Knechtle SJ
    Transplantation; 1996 Apr; 61(8):1222-8. PubMed ID: 8610422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model.
    Candinas D; Mark W; Kaever V; Miyatake T; Koyamada N; Hechenleitner P; Hancock WW
    Transplantation; 1996 Dec; 62(12):1855-60. PubMed ID: 8990376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients.
    Graeb C; Justl M; Scherer MN; Andrassy J; Frank E; Zuelke C; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):844-52. PubMed ID: 12368036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy.
    Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW
    Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
    Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
    Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine.
    Levy AE; Alexander JW
    Transplantation; 1995 Sep; 60(5):405-6. PubMed ID: 7676485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment.
    Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T
    J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation.
    Oluwole SF; Iga C; Lau H; Hardy MA
    J Heart Transplant; 1985; 4(4):385-9. PubMed ID: 2956395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo potentiation of cyclosporine immunosuppression by calcium antagonists.
    Tesi RJ; Hong J; Butt KM; Jaffe BM; McMillen MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1382-4. PubMed ID: 3274336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
    Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
    Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new rat infection-heart transplant model: effect of infection on graft survival studies.
    Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
    J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.